The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer

Mark Robson, MD, and a panel of experts discuss key terminology and definitions related to tumor and germline sequencing.

Mark Robson, MD, reviews data from a recent abstract on incidental germline findings detected by tumor-normal matched sequencing and the panelists share which platforms they utilize for tumor profiling.

A panel of experts share their experiences with interpreting information on somatic reports and provide recommendations for verifying results.

The panel of experts provide insight on how they identify patients for germline testing.

Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss the evolving role of circulating tumor DNA (ctDNA) in germline testing.

Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss operational processes and techniques for counseling patients about germline testing.